Question:

What are the main reasons for performing therapeutic drug monitoring (TDM)?

Question:

How many CPT® codes exist for definitive drug testing?

Question:

Can I report digoxin with codes from the 963XX series?

Question:

How can beneficiaries who are not leaving their home get infusion therapy?

Question:

Which drugs fall under the JW modifier policy?

Question:

Instead of reporting a second line with the discarded drug amount and price, may a provider/supplier report one line with the amount used and the adjusted price?

Question:

Can therapeutic intravenous administration of a radiopharmaceutical be reported using chemotherapy infusion codes?